(Total Views: 382)
Posted On: 07/18/2018 9:01:48 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
In conjunction with this launch, Neuraly has raised a Series A financing of $36 million from holding company, D&D Pharmatech with participation by major Korean venture funds, including: Smilegate Investment, InterVest, LB Investment, MAGNA INVESTMENT, Geon Investment and Dongkoo Bio&Pharma.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)